Cargando…
Evaluation of Toxic Amyloid β42 Oligomers in Rat Primary Cerebral Cortex Cells and Human iPS-derived Neurons Treated with 10-Me-Aplog-1, a New PKC Activator
Amyloid β42 (Aβ42), a causative agent of Alzheimer’s disease (AD), is derived extracellularly from Aβ precursor protein (APP) following the latter’s cleavage by β-secretase, but not α-secretase. Protein kinase Cα (PKCα) activation is known to increase α-secretase activity, thereby suppressing Aβ pro...
Autores principales: | Murakami, Kazuma, Yoshimura, Mayuko, Nakagawa, Shota, Kume, Toshiaki, Kondo, Takayuki, Inoue, Haruhisa, Irie, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072833/ https://www.ncbi.nlm.nih.gov/pubmed/32053979 http://dx.doi.org/10.3390/ijms21041179 |
Ejemplares similares
-
The Novel PKC Activator 10-Methyl-Aplog-1 Combined with JQ1 Induced Strong and Synergistic HIV Reactivation with Tolerable Global T Cell Activation
por: Washizaki, Ayaka, et al.
Publicado: (2021) -
Euthyphro ; Aplogy ; Crito ; Phaedo ; Phaedrus : whit an english translation.
por: Platón
Publicado: (1960) -
A Toxic Conformer of Aβ42 with a Turn at 22–23 is a Novel Therapeutic Target for Alzheimer’s Disease
por: Izuo, Naotaka, et al.
Publicado: (2017) -
Three Structural Features of Functional Food Components and Herbal Medicine with Amyloid β42 Anti-Aggregation Properties
por: Murakami, Kazuma, et al.
Publicado: (2019) -
Formation of the 42-mer Amyloid β
Radical and the Therapeutic Role of Superoxide Dismutase in Alzheimer's Disease
por: Murakami, Kazuma, et al.
Publicado: (2011)